Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.

MLA

Pavone, Carlo, et al. “Safety and Tolerability of Local Treatment with Iloprost, a Prostacyclin Analogue, in Patients with Peyronie’s Disease: A Phase I Study.” BJU International, vol. 110, no. 1, July 2012, pp. 117–21. EBSCOhost, https://doi.org/10.1111/j.1464-410X.2011.10733.x.

APA

Pavone, C., Napoli, G., Caruana, G., Alonge, V., Usala, M., & Abbadessa, D. (2012). Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie’s disease: a phase I study. BJU International, 110(1), 117–121. https://doi.org/10.1111/j.1464-410X.2011.10733.x

Chicago

Pavone, Carlo, Giancarlo Napoli, Giovanni Caruana, Vincenza Alonge, Manuela Usala, and Daniela Abbadessa. 2012. “Safety and Tolerability of Local Treatment with Iloprost, a Prostacyclin Analogue, in Patients with Peyronie’s Disease: A Phase I Study.” BJU International 110 (1): 117–21. doi:10.1111/j.1464-410X.2011.10733.x.